Cargando…
Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer’s Disease Diagnosis
An accurate and early diagnosis of Alzheimer’s disease (AD) is important to select optimal patient care and is critical in current clinical trials targeting core AD neuropathological features. The past decades, much progress has been made in the development and validation of cerebrospinal fluid (CSF...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
IOS Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870045/ https://www.ncbi.nlm.nih.gov/pubmed/29562530 http://dx.doi.org/10.3233/JAD-170680 |